ORGANIZING COMMITTEE

INTERNATIONAL FACULTY

 ABSTRACT

Abstract Submission Guidelines

Abstract Title

• Please write the title in UPPER CASE and should be limited to 25 words.
• Followed by authorship and Institutional affiliation
• Preferred presentation type should be mentioned here: oral or paper or either

Abstract Text

• Abstract should be limited to 300 words and is inclusive of sub-headings.
• Abstracts should clearly state the following:
  • Background and Aims
  • Methods
  • Results
  • Conclusions
• The abstract may include one table or graph.
• Abstracts that merely state that results will be subject to rejection
• Use only standard abbreviations. Abbreviations must be consistent and be defined on 1^st usage, then use of abbreviation.
• Disease names should be written without apostrophes, for example: Wilms tumour, Burkitt lymphoma, Hodgkin disease, etc. Please do not refer to patients by their diseases e.g., ‘Wilms tumour patients’ or ALL patients’. Instead identify them as ‘patients with Wilms tumour; and ‘patients with ALL’.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.
• ecimal points must be displayed as periods (4.89) not commas (4,89).
• Numbers beginning with a decimal point should be preceded by a zero.
• Periods should be used in numbers for decimal points, not commas i.e., P=0.015
• All measurements must be in metric units.
• An acknowledgement with an identification (unique) number shall be shared with you on receipt of your abstract. Please refer to this abstract number in all correspondence regarding the abstract. Do check your spam/ junk folder if you do not see an acknowledgement in your mailbox.
• Please contact the conference secretariat if you do not receive acknowledgement of abstract within 3 working days of submission.
• Please do not submit multiple copies of the same abstract.
• If the application is not submitted in the prescribed format (as mentioned above), it will not be considered for review.

 Limitations:

• Abstracts presented earlier cannot be submitted unless there is significant new data.
• Case reports and small institutional series of limited added scientific value are not encouraged.
• Presenting authors must be a registered participant. Only abstracts of authors who have their registration process completed, by the abstract submission deadline, will be considered for review.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• All abstracts should be submitted and presented in English with accurate grammar and spelling of a quality suitable for publication.
• Disclosure of Conflicts of Interest – Abstract submitters should disclose any conflict of interests while submitting the abstract.
• Instructions for preparation of presentations will be made available on the website.

Important Information

• Last date for abstract submission is 31st Dec 2022
• All abstracts must be submitted by email to RGCON2023@gmail.com.
• Notification regarding acceptance of the submission will be sent to the author on the email provided while submitting the abstract.
• The scientific committee reserves the right to accept/ reject/ assign a different presentation type to all the abstracts submitted.